Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel

Hiraku Kokubu; Takeshi Nakanishi; Takeshi Kato; Noriki Fujimoto

doi:10.1159/000530640

Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel

Case Rep Oncol. 2023 May 23;16(1):347-350. doi: 10.1159/000530640. eCollection 2023 Jan-Dec.

Authors

Hiraku Kokubu¹, Takeshi Nakanishi¹, Takeshi Kato¹, Noriki Fujimoto¹

Affiliation

¹ Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.

Abstract

We present a rare phenomenon of a soft tumor hanging on the woman's left upper arm that underwent necrosis from the distal aspect during chemotherapy for pancreatic cancer. The benign tumor, pedunculated lipofibroma, originally had normal color for 10 years and then became necrotic when she was treated with gemcitabine and nab-paclitaxel. Necrosis stopped in conjunction with chemotherapy cessation. Dermatologists must remember that nab-paclitaxel could develop necrosis of a skin tumor.

Keywords: Chemotherapy; Necrosis; Pedunculated lipofibroma.

Publication types

Case Reports

Grants and funding

The authors have no funding sources relevant to this report.